Lundbeck has taken part in a $67m series C round for Amplyx Pharmaceuticals, which is developing treatments for life-threatening fungal infections.

Cardiovascular therapy developer Milestone Pharmaceuticals will use proceeds from the Novo-led round to advance its lead candidate to a phase 3 clinical trial.

The Intel, Recruit and New York Life-backed machine learning technology developer has added capital to a round that now totals $67.2m according to a securities filing.

The $53.6m round, which included Elefirst Science & Technology, will support Haimawan in developing its mobile content cloud computing offering.

The Bright Lifecare spinout, which counts Intel Capital as an investor, has now raised $37m in total, after securing $15m in a round led by HBM Healthcare.

Existing backers Comcast and Qualcomm were joined by investors including AGL and Liberty Mutual for a series C round that took the smart lock developer's total funding to $75m.

The round, which was co-led by Pfizer, will support clinical trials of Complexa's kidney disease and pulmonary arterial hypertension treatments.

English language learning platform developer Liulishuo has closed a Hearst Ventures-backed round that was co-led by China Media Capital and Wu Capital.

The robotics artificial intelligence developer, which counts Samsung, Wipro and ABB as investors, has raised $50m in a Khosla Ventures-led series C round.